Meei‐Huey Jeng

2.2k total citations
30 papers, 1.9k citations indexed

About

Meei‐Huey Jeng is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Meei‐Huey Jeng has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Genetics and 8 papers in Oncology. Recurrent topics in Meei‐Huey Jeng's work include Virus-based gene therapy research (9 papers), Estrogen and related hormone effects (8 papers) and RNA Interference and Gene Delivery (7 papers). Meei‐Huey Jeng is often cited by papers focused on Virus-based gene therapy research (9 papers), Estrogen and related hormone effects (8 papers) and RNA Interference and Gene Delivery (7 papers). Meei‐Huey Jeng collaborates with scholars based in United States, Canada and Taiwan. Meei‐Huey Jeng's co-authors include Richard J. Santen, Chinghai Kao, Chaeyong Jung, R. A. McPherson, Wei Yue, Rakesh Kumar, Liana Adam, Thomas A. Gardner, David Chang and Daniela Matei and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Cancer.

In The Last Decade

Meei‐Huey Jeng

30 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meei‐Huey Jeng United States 19 1.2k 728 565 265 216 30 1.9k
Wenlin Shao United States 14 1.5k 1.2× 754 1.0× 480 0.8× 238 0.9× 147 0.7× 27 2.0k
Cem Elbi United States 23 1.4k 1.2× 397 0.5× 462 0.8× 219 0.8× 323 1.5× 38 2.2k
Devon A. Thompson United States 11 1.0k 0.8× 450 0.6× 377 0.7× 176 0.7× 171 0.8× 12 1.6k
D. Dubik Canada 9 1.4k 1.1× 483 0.7× 462 0.8× 352 1.3× 87 0.4× 10 1.9k
Patricia V. Elizalde Argentina 28 1.1k 0.9× 489 0.7× 1.0k 1.8× 478 1.8× 131 0.6× 60 2.1k
Oliver Treeck Germany 25 734 0.6× 732 1.0× 543 1.0× 340 1.3× 115 0.5× 87 1.7k
Erika Krasnickas Keeton United States 10 1.6k 1.3× 935 1.3× 589 1.0× 357 1.3× 502 2.3× 19 2.3k
Ken C. N. Chang United States 13 1.2k 1.0× 740 1.0× 469 0.8× 391 1.5× 61 0.3× 21 1.8k
Hisashi Hirakawa Japan 24 805 0.7× 741 1.0× 839 1.5× 752 2.8× 286 1.3× 63 2.0k
Rosemary E. Hall Australia 17 701 0.6× 843 1.2× 531 0.9× 237 0.9× 189 0.9× 18 1.5k

Countries citing papers authored by Meei‐Huey Jeng

Since Specialization
Citations

This map shows the geographic impact of Meei‐Huey Jeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meei‐Huey Jeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meei‐Huey Jeng more than expected).

Fields of papers citing papers by Meei‐Huey Jeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meei‐Huey Jeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meei‐Huey Jeng. The network helps show where Meei‐Huey Jeng may publish in the future.

Co-authorship network of co-authors of Meei‐Huey Jeng

This figure shows the co-authorship network connecting the top 25 collaborators of Meei‐Huey Jeng. A scholar is included among the top collaborators of Meei‐Huey Jeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meei‐Huey Jeng. Meei‐Huey Jeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Liyu, Li‐Yun Chang, Wen‐Hung Kuo, et al.. (2014). Correction to: Prognostic Features of Signal Transducer and Activator of Transcription 3 in an ER(+) Breast Cancer Model System. IUScholarWorks (Indiana University). 1 indexed citations
2.
Steding, Catherine E., et al.. (2011). The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis. Immunology. 133(2). 221–238. 106 indexed citations
3.
Xiong, Li, et al.. (2010). Docetaxel increases antitumor efficacy of oncolytic prostate‐restricted replicative adenovirus by enhancing cell killing and virus distribution. The Journal of Gene Medicine. 12(6). 516–527. 6 indexed citations
4.
Goetz, John A., Yehia Mechref, Pilsoo Kang, Meei‐Huey Jeng, & Miloš V. Novotný. (2008). Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconjugate Journal. 26(2). 117–131. 78 indexed citations
5.
Li, Xiong, Yan-Ping Zhang, Shaobo Zhang, et al.. (2007). Fas Ligand Delivery by a Prostate-Restricted Replicative Adenovirus Enhances Safety and Antitumor Efficacy. Clinical Cancer Research. 13(18). 5463–5473. 18 indexed citations
6.
Jung, Chaeyong, Youhong Liu, Yanping Zhang, et al.. (2006). Anti‐tumor efficacy of a transcriptional replication‐competent adenovirus, Ad‐OC‐E1a, for osteosarcoma pulmonary metastasis. The Journal of Gene Medicine. 8(6). 679–689. 16 indexed citations
7.
Matei, Daniela, David Chang, & Meei‐Huey Jeng. (2004). Imatinib Mesylate (Gleevec) Inhibits Ovarian Cancer Cell Growth through a Mechanism Dependent on Platelet-Derived Growth Factor Receptor α and Akt Inactivation. Clinical Cancer Research. 10(2). 681–690. 103 indexed citations
8.
Jung, Chaeyong, et al.. (2004). HOXB13 Homeodomain Protein Suppresses the Growth of Prostate Cancer Cells by the Negative Regulation of T-Cell Factor 4. Cancer Research. 64(9). 3046–3051. 88 indexed citations
9.
Jung, Chaeyong, et al.. (2004). HOXB13 Induces Growth Suppression of Prostate Cancer Cells as a Repressor of Hormone-Activated Androgen Receptor Signaling. Cancer Research. 64(24). 9185–9192. 118 indexed citations
10.
Lee, Sang Jin, Yanping Zhang, Sang Don Lee, et al.. (2004). Targeting Prostate Cancer with Conditionally Replicative Adenovirus Using PSMA Enhancer. Molecular Therapy. 10(6). 1051–1058. 16 indexed citations
11.
Lee, Sang Jin, Xiumei Yang, Chaeyong Jung, et al.. (2003). NFATc1 with AP-3 Site Binding Specificity Mediates Gene Expression of Prostate-specific-membrane-antigen. Journal of Molecular Biology. 330(4). 749–760. 28 indexed citations
12.
Santen, Richard J., R. A. McPherson, Rakesh Kumar, et al.. (2002). The role of mitogen-activated protein (MAP) kinase in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 80(2). 239–256. 343 indexed citations
13.
Lee, Sang Jin, Thomas A. Gardner, Chaeyong Jung, et al.. (2002). Novel Prostate-Specific Promoter Derived from PSA and PSMA Enhancers. Molecular Therapy. 6(3). 415–421. 69 indexed citations
14.
Santen, Richard J., Meei‐Huey Jeng, Jiping Wang, et al.. (2001). Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients. The Journal of Steroid Biochemistry and Molecular Biology. 79(1-5). 115–125. 74 indexed citations
15.
Jeng, Meei‐Huey, Wei Yue, Anne C. Eischeid, Jiping Wang, & Richard J. Santen. (2000). Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells. Breast Cancer Research and Treatment. 62(3). 167–175. 84 indexed citations
16.
DiRenzo, James, et al.. (1999). Segregation of steroid receptor coactivator-1 from steroid receptors in mammary epithelium. Proceedings of the National Academy of Sciences. 96(1). 208–213. 60 indexed citations
17.
Jeng, Meei‐Huey, Chinghai Kao, Lakshmi Sivaraman, et al.. (1998). Reconstitution of Estrogen-Dependent Transcriptional Activation of an Adenoviral Target Gene in Select Regions of the Rat Mammary Gland1. Endocrinology. 139(6). 2916–2925. 15 indexed citations
18.
Jeng, Meei‐Huey, Margaret A. Shupnik, Timothy P. Bender, et al.. (1998). Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer Cells1. Endocrinology. 139(10). 4164–4174. 150 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenlin Shao Breakdown of academic impact, for papers by Cem Elbi Breakdown of academic impact, for papers by Devon A. Thompson Breakdown of academic impact, for papers by D. Dubik Breakdown of academic impact, for papers by Patricia V. Elizalde Breakdown of academic impact, for papers by Oliver Treeck Breakdown of academic impact, for papers by Erika Krasnickas Keeton Breakdown of academic impact, for papers by Ken C. N. Chang Breakdown of academic impact, for papers by Hisashi Hirakawa Breakdown of academic impact, for papers by Rosemary E. Hall
Rankless by CCL
2026